These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 30818051)

  • 1. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabricating polydopamine-coated MoSe
    Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
    Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition.
    Li XD; Wang Z; Wang XR; Shao D; Zhang X; Li L; Ge MF; Chang ZM; Dong WF
    Int J Nanomedicine; 2019; 14():3967-3982. PubMed ID: 31239666
    [No Abstract]   [Full Text] [Related]  

  • 6. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
    Cheng X; Li D; Lin A; Xu J; Wu L; Gu H; Huang Z; Liu J; Zhang Y; Yin X
    Int J Nanomedicine; 2018; 13():3661-3677. PubMed ID: 29983561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual stimuli-responsive nanoplatform based on core-shell structured graphene oxide/mesoporous silica@alginate.
    Li S; Cao C; Gao J; Li K; Kang J; Wu D; Kong Y
    Int J Biol Macromol; 2021 Apr; 175():209-216. PubMed ID: 33549662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Graphene Oxide Nanocomposite Effective for Combined Chemo/Photo Therapy Against Non-Small Cell Lung Cancer.
    Zhang P; Zheng L; Zhang X; Liu M; Li M; Zhang M; Wu JL; Choi MMF; Bian W
    Int J Nanomedicine; 2024; 19():7493-7508. PubMed ID: 39081895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular nanomaterials based on hollow mesoporous drug carriers and macrocycle-capped CuS nanogates for synergistic chemo-photothermal therapy.
    Yang J; Dai D; Lou X; Ma L; Wang B; Yang YW
    Theranostics; 2020; 10(2):615-629. PubMed ID: 31903141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
    Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
    Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of Rhenium Disulfide/Mesoporous Silica Core-Shell Nanoparticles for a pH-Responsive Drug Release and Combined Chemo-Photothermal Therapy.
    Na H; Carrier J; Oyon S; Lai CY
    ACS Appl Bio Mater; 2024 May; 7(5):3337-3345. PubMed ID: 38700956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and performance evaluation of pH-responsive oxidized hyaluronic acid hollow mesoporous silica nanoparticles.
    Enyu X; Xinbo L; Xuelian C; Huimin C; Yin C; Yan C
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):128656. PubMed ID: 38065461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Ocular Safety of Hollow Mesoporous Organosilica Nanoparticles with Different Tetrasulfur Bond Content.
    Li J; Gao Z; Li N; Yao L; Liu C; Xu C; Ren X; Wang A; Gao S; Wang M; Gao X; Li K; Wang J
    Int J Nanomedicine; 2024; 19():7123-7136. PubMed ID: 39055375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene Oxide-Template Gold Nanosheets as Highly Efficient Near-Infrared Hyperthermia Agents for Cancer Therapy.
    He S; Li J; Chen M; Deng L; Yang Y; Zeng Z; Xiong W; Wu X
    Int J Nanomedicine; 2020; 15():8451-8463. PubMed ID: 33149586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
    Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
    Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer.
    Thapa RK; Nguyen HT; Gautam M; Shrestha A; Lee ES; Ku SK; Choi HG; Yong CS; Kim JO
    Drug Deliv; 2017 Nov; 24(1):1690-1702. PubMed ID: 29098877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored Covalent Organic Framework Platform: From Multistimuli, Targeted Dual Drug Delivery by Architecturally Engineering to Enhance Photothermal Tumor Therapy.
    Rahmani Khalili N; Banitalebi Dehkordi A; Amiri A; Mohammadi Ziarani G; Badiei A; Cool P
    ACS Appl Mater Interfaces; 2024 Jun; 16(22):28245-28262. PubMed ID: 38770930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
    Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
    J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
    Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
    Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.